Antifolate antimalarial resistance in southeast Africa: a population-based analysis
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The dominance of the N51I + S108N PfDHFR double mutant within these haplotypes supports a stepwise model of antifolate resistance evolution in which S108N arises first, followed by N51I and C59R, before fixation of the triple mutant50,51”
From Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia (2026) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- Marsh, 1998, Malaria disaster in Africa, Lancet, 352, 924, 10.1016/S0140-6736(05)61510-3 · DOI · Paper page
- Wang, 1997, Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins, Mol Biochem Parasitol, 89, 161, 10.1016/S0166-6851(97)00114-X · DOI · Paper page
- Sims, 1998, On “The efficacy of antifolate antimalarial combinations in Africa”, Parasitology Today, 14, 136, 10.1016/S0169-4758(97)01203-9 · DOI
- Hastings, 2002, The evolution of drug-resistant malaria: the role of drug elimination half-life, Philos Trans R Soc London Ser B, 357, 505, 10.1098/rstb.2001.1036 · DOI · Paper page
- Wu, 1996, Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine, Proc Natl Acad Sci USA, 93, 1130, 10.1073/pnas.93.3.1130 · DOI · Paper page
- Triglia, 1997, Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum, Proc Natl Acad Sci USA, 94, 13944, 10.1073/pnas.94.25.13944 · DOI · Paper page
- Triglia, 1998, Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria, EMBO J, 17, 3807, 10.1093/emboj/17.14.3807 · DOI · Paper page
- Omar, 2001, Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?, Trans R Soc Trop Med Hyg, 95, 315, 10.1016/S0035-9203(01)90250-0 · DOI
- Kublin, 2002, Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria, J Infect Dis, 185, 380, 10.1086/338566 · DOI · Paper page
- Paget-McNichol, 2002, Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum, Parasitology, 1122, 497
- White, 1999, Averting a malaria disaster, Lancet, 353, 1965, 10.1016/S0140-6736(98)07367-X · DOI · Paper page
- Wootton, 2002, Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum, Nature, 417, 320, 10.1038/nature00813 · DOI · Paper page
- Bredenkamp, 2001, Failure of sulphadoxine-pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu-Natal, S Afr Med J, 91, 970
- Pearce, 2003, Molecular determination of point mutation haplotypes in the dhfr and dhps of P falciparum in three regions of northern Tanzania, Antimicrob Agents Chemother, 47, 1347, 10.1128/AAC.47.4.1347-1354.2003 · DOI
- Bahl, 2002, PlasmoDB: the Plasmodium genome resource. An integrated database providing tools for accessing, analysing and mapping expression and sequence data (both finished and unfinished), Nucleic Acids Res, 30, 87, 10.1093/nar/30.1.87 · DOI
- Su, 1996, Toward a high resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats, Genomics, 33, 430, 10.1006/geno.1996.0218 · DOI · Paper page
- Mberu, 2000, The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi Kenya, Am J Trop Med Hyg, 62, 396, 10.4269/ajtmh.2000.62.396 · DOI
- Nzila, 2000, Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum, J Infect Dis, 181, 2023, 10.1086/315520 · DOI
- Curtis, 1998, In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sufadoxine but not chlorproguanildapsone treatment, J Infect Dis, 177, 1429, 10.1086/517831 · DOI
- Plowe, 1997, Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine sulfadoxine use and resistance, J Infect Dis, 176, 1590, 10.1086/514159 · DOI · Paper page
- Cowman, 1998, Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase thymidylate synthase gene of Plasmodium falciparum, Proc Natl Acad Sci USA, 85, 9109, 10.1073/pnas.85.23.9109 · DOI · Paper page
- Peterson, 1988, Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria, Proc Natl Acad Sci USA, 85, 9114, 10.1073/pnas.85.23.9114 · DOI · Paper page
- Su, 1997, Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine resistant P falciparum in Southeast Asia and Africa, Cell, 91, 593, 10.1016/S0092-8674(00)80447-X · DOI · Paper page
- Cortese, 2002, Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America, J Inf Dis, 186, 999, 10.1086/342946 · DOI · Paper page
- Kublin, 1998, Molecular assays for surveillance of antifolate-resistant malaria, Lancet, 351, 1629, 10.1016/S0140-6736(98)24022-0 · DOI
- Avery Jones, 1958, Mass treatment with pyrimethamine: a study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya Sept, 1952–Sept, 1953, Trans R Soc Trop Med Hyg, 52, 547, 10.1016/0035-9203(58)90104-4 · doi:10.1016/0035-9203(58)90104-4
- Payne, 1988, Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum?, Parasitol Today, 4, 112, 10.1016/0169-4758(88)90042-7 · doi:10.1016/0169-4758(88)90042-7
Cited by
Antimalarial drug resistance: An overview
Parija, S., & Antony, H. (2016) · Tropical Parasitology · doi:10.4103/2229-5070.175081 · Cited by 215
Letebo, A., Vanheer, L. N., Engdaw, M., Ejigu, L. A., Hailu Alemayehu, D., Deressa, J. D., Adnew, B., Ayele, A., Bezabih, M. K., Demisse, M., et al. (2026) · Nature Microbiology · doi:10.1038/s41564-026-02420-5 · Cited by 4
Metadata
- Authors
- Roper, C., Pearce, R., Bredenkamp, B., Gumede, J., Drakeley, C., Mosha, F., Chandramohan, D., & Sharp, B.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 361
- Issue
- 9364
- Pages
- 1174-1181
- ISSN
- 0140-6736
- Cited by
- 237
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antifolate antimalarial resistance in southeast Africa: a population-based analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(03)12951-0
- The paper
- Roper, C., Pearce, R., Bredenkamp, B., Gumede, J., Drakeley, C., Mosha, F., Chandramohan, D., & Sharp, B. (2003). Antifolate antimalarial resistance in southeast Africa: a population-based analysis. The Lancet. https://doi.org/10.1016/s0140-6736(03)12951-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.